In last trading session, Sana Biotechnology Inc (NASDAQ:SANA) saw 2.64 million shares changing hands with its beta currently measuring 1.68. Company’s recent per share price level of $1.71 trading at -$0.02 or -1.16% at ring of the bell on the day assigns it a market valuation of $384.79M. That closing price of SANA’s stock is at a discount of -514.04% from its 52-week high price of $10.50 and is indicating a premium of 26.32% from its 52-week low price of $1.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.54 million shares which gives us an average trading volume of 3.67 million if we extend that period to 3-months.
For Sana Biotechnology Inc (SANA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Upright in the red during last session for losing -1.16%, in the last five days SANA remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $1.71 price level, adding 10.47% to its value on the day. Sana Biotechnology Inc’s shares saw a change of 4.91% in year-to-date performance and have moved 0.59% in past 5-day. Sana Biotechnology Inc (NASDAQ:SANA) showed a performance of -29.34% in past 30-days. Number of shares sold short was 40.25 million shares which calculate 10.97 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 8 to the stock, which implies a rise of 78.62% to its current value. Analysts have been projecting 8 as a low price target for the stock while placing it at a high target of 8. It follows that stock’s current price would drop -367.84% in reaching the projected high whereas dropping to the targeted low would mean a loss of -367.84% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -10.60% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 25.01% while estimates for its earnings growth in next 5 years are of 11.81%.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
Insiders are in possession of 8.58% of company’s total shares while institution are holding 93.58 percent of that, with stock having share float percentage of 102.37%. Investors also watch the number of corporate investors in a company very closely, which is 93.58% institutions for Sana Biotechnology Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at SANA for having 27.17 million shares of worth $148.35 million. And as of 2024-06-30, it was holding 11.5894 of the company’s outstanding shares.
The second largest institutional holder is FLAGSHIP PIONEERING INC., which was holding about 25.0 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.6645 of outstanding shares, having a total worth of $136.51 million.
On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and SMALLCAP WORLD FUND INC are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 9.6 shares of worth $16.41 million or 4.27% of the total outstanding shares. The later fund manager was in possession of 5.45 shares on Mar 31, 2025 , making its stake of worth around $9.32 million in the company or a holder of 2.42% of company’s stock.
